Literature DB >> 9469491

Prevalence of hepatitis C and G virus infection in chronic hemodialysis patients.

M de Medina1, M Ashby, V Schlüter, M Hill, B Leclerq, J P Pennell, L J Jeffers, K R Reddy, E R Schiff, G Hess, G O Perez.   

Abstract

An RNA virus designated hepatitis G virus (HGV) has been recently identified in patients with acute and chronic liver disease. HGV is transfusion transmissible, it has global distribution, and it is present in the volunteer blood donor population in the United States. One hundred sixty patients undergoing maintenance hemodialysis at the University of Miami-affiliated unit were evaluated. There were 99 men and 61 women ranging in age from 22 to 80 years. Sixty percent had a history of blood transfusion, 6% had a history of drug abuse, and 9% were infected with the human immunodeficiency virus. HGV-RNA was detected by reverse-transcriptase polymerase chain reaction with amplification of two independent regions (5'-nontranslated region and NS5a coding region). Detection of digoxigenin-labeled amplification products with specific capture probes to the coding and noncoding regions was performed with the Enzymun-test DNA on an ES-300 Immunoassay System (Boehringer-Mannheim, Mannheim, Germany). Hepatitis C antibodies were measured with anti-hepatitis C virus enzyme-linked immunosorbent third-generation assays and hepatitis C virus RNA by reverse-transcriptase polymerase chain reaction. There were 32 (20%) patients with detectable HGV RNA with both primer pairs. Because of possible mutations, the HGV virus may be detectable only with one primer pair. We considered the latter as indeterminate: 12 had detectable levels to the NS5a region only, seven to the 5'-nontranslated region, and six had borderline results. Detectable and indeterminate samples were confirmed by repeat measurements in a new blood sample. Seven of 24 (29%) patients with detectable hepatitis C virus RNA had coexisting HGV with one or both HGV primer pairs (four with both and three with one). Five patients were hepatitis B surface antigen positive and HGV negative. We conclude that HGV infection is prevalent in our dialysis patients. The clinical significance of HGV infection remains to be established.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9469491     DOI: 10.1053/ajkd.1998.v31.pm9469491

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  8 in total

1.  Distribution of HCV genotypes in patients with end-stage renal disease according to type of dialysis treatment.

Authors:  Haldun Selcuk; Mehmet Kanbay; Murat Korkmaz; Gurden Gur; Ali Akcay; Hande Arslan; Nurhan Ozdemir; Ugur Yilmaz; Sedat Boyacioglu
Journal:  Dig Dis Sci       Date:  2006-07-26       Impact factor: 3.199

2.  Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients.

Authors:  H Hinrichsen; G Leimenstoll; G Stegen; H Schrader; U R Fölsch; W E Schmidt
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

3.  Hepatitis G virus infection in Egyptian children with chronic renal failure (single centre study).

Authors:  Ayman Mohammad Hammad; Mohammad Hosam El Deen Zaghloul
Journal:  Ann Clin Microbiol Antimicrob       Date:  2009-12-16       Impact factor: 3.944

4.  Hepatitis G virus exposure in dialysis patients.

Authors:  Ali Eslamifar; Rasool Hamkar; Amitis Ramezani; Farrokhlagha Ahmadi; Latif Gachkar; Somayeh Jalilvand; Ladan Adibi; Shahnaz Atabak; Ali Khameneh; Ramin Ghadimi; Arezoo Aghakhani
Journal:  Int Urol Nephrol       Date:  2007-09-05       Impact factor: 2.370

5.  Prevalence and risk factors of hepatitis B and C viruses among haemodialysis patients in Gaza strip, Palestine.

Authors:  Abed El-kader Y El-Ottol; Abdelraouf A Elmanama; Basim M Ayesh
Journal:  Virol J       Date:  2010-09-01       Impact factor: 4.099

6.  Seroprevalence of Hepatitis Viruses B, C, D and HIV Infection Among Hemodialysis Patients in Kerman Province, South-East Iran.

Authors:  Mohammad Javad Zahedi; Sodaif Darvish Moghaddam; Seyed Moayed Alavian; Mahdieh Dalili
Journal:  Hepat Mon       Date:  2012-05-30       Impact factor: 0.660

7.  Cancer risk among elderly persons with end-stage renal disease: a population-based case-control study.

Authors:  Fatma M Shebl; Joan L Warren; Paul W Eggers; Eric A Engels
Journal:  BMC Nephrol       Date:  2012-07-26       Impact factor: 2.388

8.  Prevalence and risk factors of hepatitis B and C viruses among hemodialysis patients in Isfahan, Iran.

Authors:  Hamid Kalantari; Shahram Ebadi; Majid Yaran; Mohammad R Maracy; Zahra Shahshahan
Journal:  Adv Biomed Res       Date:  2014-01-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.